Literature DB >> 17272510

Long-term T-cell reconstitution after hematopoietic stem-cell transplantation in primary T-cell-immunodeficient patients is associated with myeloid chimerism and possibly the primary disease phenotype.

Marina Cavazzana-Calvo1, Frédérique Carlier, Françoise Le Deist, Estelle Morillon, Pierre Taupin, David Gautier, Isabelle Radford-Weiss, Sophie Caillat-Zucman, Bénédicte Neven, Stephane Blanche, Rémi Cheynier, Alain Fischer, Salima Hacein-Bey-Abina.   

Abstract

We studied T-cell reconstitution in 31 primary T-cell-immunodeficient patients who had undergone hematopoietic stem-cell transplantation (HSCT) over 10 years previously. In 19 patients, there was no evidence of myeloid chimerism because little or no myeloablation had been performed. Given this context, we sought factors associated with good long-term T-cell reconstitution. We found that all patients having undergone full myeloablation had donor myeloid cells and persistent thymopoiesis, as evidenced by the presence of naive T cells carrying T-cell receptor excision circles (TRECs). In 9 patients with host myeloid chimerism, sustained thymic output was also observed and appeared to be associated with gammac deficiency. It is therefore possible that the complete absence of thymic progenitors characterizing this condition created a more favorable environment for thymic seeding by a population of early progenitor cells with the potential for self-renewal, thus enabling long-term (> 10 years) T-cell production.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17272510     DOI: 10.1182/blood-2006-07-029090

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  50 in total

1.  Laboratory technology for population-based screening for severe combined immunodeficiency in neonates: the winner is T-cell receptor excision circles.

Authors:  Jennifer M Puck
Journal:  J Allergy Clin Immunol       Date:  2012-01-29       Impact factor: 10.793

Review 2.  Is normal hematopoiesis maintained solely by long-term multipotent stem cells?

Authors:  Marina Cavazzana-Calvo; Alain Fischer; Frederic D Bushman; Emmanuel Payen; Salima Hacein-Bey-Abina; Philippe Leboulch
Journal:  Blood       Date:  2011-02-08       Impact factor: 22.113

Review 3.  Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Stem Cell Transplantation (HCT) for Severe Combined Immunodeficiency Patients: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT.

Authors:  Jennifer Heimall; Jennifer Puck; Rebecca Buckley; Thomas A Fleisher; Andrew R Gennery; Benedicte Neven; Mary Slatter; Elie Haddad; Luigi D Notarangelo; K Scott Baker; Andrew C Dietz; Christine Duncan; Michael A Pulsipher; Mort J Cowan
Journal:  Biol Blood Marrow Transplant       Date:  2017-01-06       Impact factor: 5.742

4.  Chemotherapy-free conditioning: one step closer.

Authors:  Andrew R Gennery; Mary A Slatter
Journal:  Blood       Date:  2014-08-07       Impact factor: 22.113

5.  Hematopoietic Stem Cell Transplantation for Severe Combined Immunodeficiency.

Authors:  Justin T Wahlstrom; Christopher C Dvorak; Morton J Cowan
Journal:  Curr Pediatr Rep       Date:  2015-03-01

Review 6.  Long term outcomes of severe combined immunodeficiency: therapy implications.

Authors:  Jennifer Heimall; Morton J Cowan
Journal:  Expert Rev Clin Immunol       Date:  2017-09-23       Impact factor: 4.473

7.  B-cell differentiation and IL-21 response in IL2RG/JAK3 SCID patients after hematopoietic stem cell transplantation.

Authors:  Alexandra M Miggelbrink; Brent R Logan; Rebecca H Buckley; Roberta E Parrott; Christopher C Dvorak; Neena Kapoor; Hisham Abdel-Azim; Susan E Prockop; David Shyr; Hélène Decaluwe; Imelda C Hanson; Alfred Gillio; Blachy J Dávila Saldaña; Hermann Eibel; Gregory Hopkins; Jolan E Walter; Jennifer S Whangbo; Donald B Kohn; Jennifer M Puck; Morton J Cowan; Linda M Griffith; Elie Haddad; Richard J O'Reilly; Luigi D Notarangelo; Sung-Yun Pai
Journal:  Blood       Date:  2018-05-04       Impact factor: 22.113

8.  Allogeneic hematopoietic cell transplantation for primary immune deficiency diseases: current status and critical needs.

Authors:  Linda M Griffith; Morton J Cowan; Donald B Kohn; Luigi D Notarangelo; Jennifer M Puck; Kirk R Schultz; Rebecca H Buckley; Mary Eapen; Naynesh R Kamani; Richard J O'Reilly; Robertson Parkman; Chaim M Roifman; Kathleen E Sullivan; Alexandra H Filipovich; Thomas A Fleisher; William T Shearer
Journal:  J Allergy Clin Immunol       Date:  2008-11-06       Impact factor: 10.793

9.  Effects of conditioning regimens and T cell depletion in hematopoietic cell transplantation for primary immune deficiency.

Authors:  Brandon M Triplett; Chong Wang; Jie Yang; Mari Dallas; Christine Hartford; Vanessa Howard; Asha Pillai; David Shook; Ashok Srinivasan; Joseph Laver; Wing Leung
Journal:  Biol Blood Marrow Transplant       Date:  2012-07-27       Impact factor: 5.742

10.  Niche recycling through division-independent egress of hematopoietic stem cells.

Authors:  Deepta Bhattacharya; Agnieszka Czechowicz; A G Lisa Ooi; Derrick J Rossi; David Bryder; Irving L Weissman
Journal:  J Exp Med       Date:  2009-11-02       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.